BIVI Logo

BioVie Inc. (BIVI) 

NASDAQ
Market Cap
$55.35M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
395 of 968
Rank in Industry
237 of 556

Largest Insider Buys in Sector

BIVI Stock Price History Chart

BIVI Stock Performance

About BioVie Inc.

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.

Insider Activity of BioVie Inc.

Over the last 12 months, insiders at BioVie Inc. have bought $10,000 and sold $0 worth of BioVie Inc. stock.

On average, over the past 5 years, insiders at BioVie Inc. have bought $118,505 and sold $352,703 worth of stock each year.

Highest buying activity among insiders over the last 12 months: DO CUONG V (President & CEO) — $10,000.

The last purchase of 10,000 shares for transaction amount of $10,000 was made by DO CUONG V (President & CEO) on 2024‑03‑04.

List of Insider Buy and Sell Transactions, BioVie Inc.

2024-03-04PurchasePresident & CEO
10,000
0.0236%
$1.00$10,000-59.25%
2023-12-01Saledirector
75,680
0.2029%
$1.69$127,899-71.43%
2023-11-30PurchasePresident & CEO
10,000
0.0263%
$1.78$17,800-73.25%
2023-09-05Saledirector
8,560
0.023%
$3.05$26,108-70.38%
2023-08-22Saledirector
10,805
0.0289%
$3.50$37,827-70.15%
2023-06-07Saledirector
5,984
0.017%
$5.81$34,782-69.90%
2023-05-22Saledirector
5,000
0.0137%
$6.50$32,506-54.90%
2023-03-28Saledirector
7,613
0.0213%
$8.52$64,870-59.33%
2023-03-27Saledirector
3,371
0.0096%
$8.52$28,711-58.32%
2021-12-07PurchaseCFO
2,000
0.0084%
$5.40$10,798-38.99%
2020-11-03Purchasedirector
2,430
0.0171%
$7.95$19,319+78.22%
2020-10-30Purchasedirector
2,570
0.0185%
$7.97$20,483+81.68%
2020-10-21Purchasedirector
5,000
0.0362%
$9.19$45,950+58.95%
2020-10-15Purchasedirector
15,100
0.1065%
$10.10$152,517+40.72%
2020-10-09Purchasedirector
282
0.002%
$9.61$2,710+50.83%
2020-10-07Purchasedirector
4,718
0.0343%
$9.42$44,444+55.36%
2020-09-22Purchasedirector
15,000
0.263%
$10.00$150,000+51.62%

Insider Historical Profitability

47.3%
DO CUONG VPresident & CEO
435854
2.453%
$3.1220
GORLIN STEVEdirector
46358
0.2609%
$3.1272+59.63%
BERMAN RICHARD Jdirector
16789
0.0945%
$3.1205
KIM JOANNE WENDYCFO
2000
0.0113%
$3.1210<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Altium Capital Management Lp$1.59M4.933.01MNew+$1.59M0.19
SABBY MANAGEMENT LLC$364,277.001.13689,135New+$364,277.000.15
The Vanguard Group$340,722.001.05644,575+83.2%+$154,734.28<0.0001
Cvi Holdings Llc$317,106.000.98599,897New+$317,106.000.33
Renaissance Technologies$184,000.000.57347,400New+$184,000.00<0.0001
BlackRock$173,344.000.54327,930-6.43%-$11,917.83<0.0001
Geode Capital Management$130,631.000.4247,106+31.73%+$31,463.28<0.0001
State Street$92,594.000.29175,168-0.33%-$303.95<0.0001
Northern Trust$61,031.000.19115,458+6%+$3,454.92<0.0001
Cerity Partners$43,684.000.1482,741+103.09%+$22,174.35<0.0001
Sheaff Brock Investment Advisors$27,171.000.0851,400+276.89%+$19,961.70<0.01
Envestnet Asset Management Inc$22,338.000.0742,258+92.86%+$10,755.63<0.0001
Bank of America$18,524.000.0635,084-3.76%-$723.35<0.0001
Charles Schwab$15,824.000.0529,9350%+$0<0.0001
Shepherd Kaplan Krochuk, LLC$15,567.000.0529,4500%+$00.01
Morgan Stanley$13,005.000.0424,601-70.37%-$30,885.09<0.0001
UBS$11,844.000.0422,390+66.39%+$4,725.96<0.0001
Cibc Private Wealth Group Llc$9,985.000.0317,8140%+$0<0.0001
Newbridge Financial Services Group Inc$8,986.000.0317,000+183.33%+$5,814.47<0.01
New York State Common Retirement Fund$9,000.000.0317,2350%+$0<0.0001
BNY Mellon$8,434.000.0315,955-2.09%-$179.73<0.0001
Millennium Management LLC$6,950.000.0213,148-64.43%-$12,588.02<0.0001
Tower Research Capital$6,498.000.0212,284+68.85%+$2,649.66<0.0001
Barclays$6,000.000.0211,158-36.68%-$3,475.35<0.0001
Virtu Financial Llc$6,000.000.0210,952-56.33%-$7,738.31<0.01
Summit Trail Advisors$5,339.000.0210,1000%+$0<0.0001
LINSCO PRIVATE LEDGER CORP$5,342.000.0210,105New+$5,342.00<0.0001
Group One Trading$5,351.000.0210,123New+$5,351.00<0.0001
Wells Fargo$4,962.000.029,386+9.08%+$412.88<0.0001
Royal Bank of Canada$4,000.000.018,093-27.74%-$1,535.65<0.0001
American International Group$3,412.000.016,454+7.44%+$236.31<0.0001
Fidelity Investments$3,267.000.016,180+3,472.25%+$3,175.55<0.0001
Advisor Group Holdings Inc$3,052.000.015,763-18.69%-$701.70<0.0001
RhumbLine Advisers$2,541.000.014,820+2.73%+$67.48<0.0001
Simplex Trading Llc$1,000.000.012,793-82.3%-$4,650.91<0.0001
Citigroup$1,434.00<0.012,713+34.51%+$367.88<0.0001
JPMorgan Chase$1,291.00<0.012,442+12.95%+$148.03<0.0001
CalSTRS$786.00<0.011,487-25.24%-$265.35<0.0001
Newedge Advisors Llc$529.00<0.011,0000%+$0<0.0001
Spire Wealth Management$793.00<0.011,496-0.27%-$2.12<0.0001
Steward Partners Investment Advisory LLC$529.00<0.011,0000%+$0<0.0001
Legal & General$224.00<0.014240%+$0<0.0001
PNC Financial Services$223.00<0.01421New+$223.00<0.0001
Sanctuary Wealth Management L L C$2.00<0.013New+$2.00<0.0001
Amalgamated Bank$0<0.01112-76.17%-$0<0.0001
Ameritas Investment Partners Inc$145.00<0.012740%+$0<0.0001
Albion Financial Group$27.00<0.01500%+$0<0.0001
Harbour Investments Inc$159.00<0.013000%+$0<0.0001
Nelson Van Denburg & Campbell Wealth Management Group LLC$0<0.011New+$0<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.